Study to Improve the Treatment of Epilepsy (SITE)

• Status: Unknown status
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess whether changing antiepileptic medication can reduce side effects and improve the quality of life in patients with epileptic seizures that are well controlled with antiepileptic drugs.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UMC Utrecht
• Collaborator: GlaxoSmithKline
• Treatments: Anticonvulsants

Criteria

Inclusion Criteria:

• Aged 18 years or older

• Treatment: antiepileptic drugs for epilepsy

• No change in medication during last 6 months

• No obvious clinical reason to change medication immediately

Exclusion Criteria:

• Concurrent disease or disorder that might interfere with the conduct of the study

• Inability to comply to the protocol

• Impaired intellectual functioning, leading to inability to comply to the protocol and complete the necessary questionnaires